34.39

7.64% -2.5987

Crispr Therapeutics Ag (CRSP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché CRSP Giù? Forum Previsione

Precedente Chiudi:

$36.99

Aprire:

$35.75

Volume 24 ore:

1.25M

Relative Volume:

0.63

Capitalizzazione di mercato:

$3.26B

Reddito:

$170.10M

Utile/perdita netta:

$-239.59M

Rapporto P/E:

-12.28

EPS:

-2.8

Flusso di cassa netto:

$-191.20M

1 W Prestazione:

-19.84%

1M Prestazione:

-22.21%

6M Prestazione:

-27.28%

1 anno Prestazione:

-49.88%

Intervallo 1D:

$32.96

$35.75

Intervallo di 1 settimana:

$32.96

$42.50

Portata 52W:

$32.96

$68.39

Crispr Therapeutics Ag Stock (CRSP) Company Profile

Nome

Crispr Therapeutics Ag

Settore

Healthcare (1167)

Industria

Biotechnology (671)

Telefono

(617) 315-4600

Indirizzo

BAARERSTRASSE 14, ZUG

Dipendente

Cinguettio

@crisprtx

Prossima data di guadagno

2024-12-05

Ultimi documenti SEC

CRSP's Discussions on Twitter

Confronta CRSP con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRSP Crispr Therapeutics Ag	34.42	3.26B	170.10M	-239.59M	-191.20M	-2.80
VRTX Vertex Pharmaceuticals Inc	483.29	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	632.26	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	579.01	35.93B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	264.82	33.98B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	269.56	28.24B	3.81B	-644.79M	-669.77M	-6.24

Crispr Therapeutics Ag Stock (CRSP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-14	Aggiornamento	Evercore ISI	In-line → Outperform
2025-02-12	Aggiornamento	TD Cowen	Sell → Hold
2025-02-03	Iniziato	H.C. Wainwright	Buy
2024-08-06	Reiterato	Needham	Buy
2024-08-02	Iniziato	Rodman & Renshaw	Buy
2024-06-28	Ripresa	Guggenheim	Neutral
2024-02-15	Iniziato	Wolfe Research	Peer Perform
2023-12-11	Downgrade	TD Cowen	Market Perform → Underperform
2023-10-17	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-09-27	Iniziato	Mizuho	Buy
2023-08-17	Aggiornamento	Citigroup	Neutral → Buy
2023-05-30	Iniziato	William Blair	Outperform
2023-04-13	Iniziato	Cantor Fitzgerald	Overweight
2023-03-21	Iniziato	Bernstein	Mkt Perform
2023-03-17	Iniziato	Bryan Garnier	Buy
2023-03-07	Iniziato	Robert W. Baird	Neutral
2022-10-11	Iniziato	Morgan Stanley	Underweight
2022-08-09	Downgrade	Barclays	Overweight → Equal Weight
2022-06-23	Downgrade	Evercore ISI	Outperform → In-line
2022-06-17	Iniziato	BMO Capital Markets	Outperform
2022-04-28	Iniziato	Credit Suisse	Neutral
2021-12-07	Iniziato	Cowen	Market Perform
2021-10-19	Iniziato	SVB Leerink	Outperform
2021-06-14	Aggiornamento	Citigroup	Sell → Neutral
2021-04-21	Aggiornamento	Jefferies	Hold → Buy
2021-03-04	Iniziato	JMP Securities	Mkt Outperform
2020-12-10	Reiterato	Chardan Capital Markets	Buy
2020-12-10	Downgrade	Jefferies	Buy → Hold
2020-12-10	Reiterato	Needham	Buy
2020-12-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2020-10-05	Iniziato	BofA Securities	Buy
2020-07-28	Reiterato	Needham	Buy
2020-07-14	Iniziato	SunTrust	Buy
2020-06-15	Reiterato	Canaccord Genuity	Buy
2020-03-05	Iniziato	Stifel	Hold
2020-02-03	Downgrade	Evercore ISI	Outperform → In-line
2019-11-19	Aggiornamento	William Blair	Mkt Perform → Outperform
2019-11-12	Aggiornamento	Oppenheimer	Perform → Outperform
2019-08-01	Iniziato	Jefferies	Buy
2019-07-26	Iniziato	Canaccord Genuity	Buy
2019-06-10	Iniziato	ROTH Capital	Buy
2019-04-12	Iniziato	Evercore ISI	Outperform
2019-03-14	Iniziato	William Blair	Mkt Perform
2019-01-28	Downgrade	Goldman	Buy → Neutral
2019-01-22	Downgrade	Citigroup	Neutral → Sell

Mostra tutto

Crispr Therapeutics Ag Borsa (CRSP) Ultime notizie

09:31 AM

Intellia Focuses on Pipeline Development Amid Stiff Competition - Zacks Investment Research

09:31 AM

Mar 30, 2025

82,095 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Bought by Raymond James Financial Inc. - MarketBeat

Mar 30, 2025

How to Take Advantage of moves in (CRSP) - Stock Traders Daily

Mar 30, 2025

Avantax Advisory Services Inc. Invests $269,000 in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 30, 2025

Mar 29, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Has $1.43 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 29, 2025

Loomis Sayles & Co. L P Lowers Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 29, 2025

Mar 28, 2025

Promising Genomics & Synthetic Biology Stocks to Consider in 2025 - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

CRISPR Therapeutics (NasdaqGM:CRSP) COO Departure Announced Following 7% Share Price Decline - Yahoo Finance

Mar 27, 2025

Mar 26, 2025

CRISPR Therapeutics COO to step down in April By Investing.com - Investing.com South Africa

Mar 26, 2025

CRISPR Therapeutics Announces Transition of Chief Operating Officer - GlobeNewswire

Mar 26, 2025

This CRISPR Therapeutics Insider Increased Their Holding In The Last Year - Yahoo Finance

Mar 26, 2025

Crispr therapeutics’ general counsel sells shares worth $131,317 By Investing.com - Investing.com Australia

Mar 26, 2025

HighTower Advisors LLC Has $1.25 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Mar 26, 2025

Mar 25, 2025

Is CRISPR Therapeutics AG (CRSP) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025

CRISPR Therapeutics Set To Reach Previous Heights (NASDAQ:CRSP) - Seeking Alpha

Mar 25, 2025